‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Key Milestones2 |
|
|---|---|
| Call for patient input posted | August 29, 2018 |
| Patient group input closed | October 19, 2018 |
| Clarification:
- Patient input submission received from the Carcinoid Neuroendocrine Tumour Society - Canada |
|
| Patient input summary sent for review to patient input groups | October 29, 2018 |
| Patient group comments on input summary closed | November 05, 2018 |
| Clarification:
- Patient input summary feedback received |
|
| Submission received | September 27, 2018 |
| Submission accepted for review | October 12, 2018 |
| Review initiated | October 15, 2018 |
| Draft Canada's Drug Agency review report(s) sent to sponsor | January 07, 2019 |
| Comments from sponsor on draft Canada's Drug Agency review report(s) received | January 16, 2019 |
| Redaction requests from sponsor on draft Canada's Drug Agency review report(s) received | January 23, 2019 |
| Canada's Drug Agency review team's comments on draft Canada's Drug Agency review report(s) sent to sponsor | February 07, 2019 |
| Canadian Drug Expert Committee (CDEC) meeting | February 20, 2019 |
| CDEC recommendation & redacted Canada's Drug Agency review report(s) sent to sponsor and drug plans | March 06, 2019 |
| Embargo period ended and validation of redacted Canada's Drug Agency review report(s) received | March 22, 2019 |
| Clarification:
- Request for extension to embargo period received from the manufacturer - Embargo extension request granted - Reconsideration requested - Target CDEC reconsideration meeting date to be determined |
|
| Sponsor's request for reconsideration placed on CDEC agenda | June 19, 2019 |
| CDEC Final Recommendation issued to sponsor and drug plans | June 26, 2019 |
| CDEC Final Recommendation posted | July 03, 2019 |
| Final Canada's Drug Agency review report(s) posted | July 25, 2019 |
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.